Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review

Int J Immunopathol Pharmacol. 2022 Jan-Dec:36:3946320221141802. doi: 10.1177/03946320221141802.

Abstract

Objective: With the global epidemic of coronavirus disease 2019 (COVID-19), vaccination rates are increasing globally. This study evaluated the relevant clinical manifestations of vaccinated COVID-19 patients.

Methods: We searched carefully in 11 databases such as PubMed, Embase, Scopus, Cochrane Library, Web of Science, Ovid, China National Knowledge Infrastructure Database, Wan Fang Data, Sinomed, VIP Database, and Reading Showing Database up to 26 March 2022. To search for articles that have described the characteristics of vaccinated patients including epidemiological and clinical symptoms. Statistical analysis of the extracted data using STATA 14.0.

Results: A total of 58 articles and 263,708 laboratory-confirmed COVID-19 patients were included. Most of the patients in the vaccinated group had more asymptomatic infection and fewer severe illnesses. There were significant differences in ethnicity, and strain infected with COVID-19, and comorbidities (hyperlipidemia, diabetes, obesity, kidney disease, immunocompromised, cardiovascular disease, and tumor) and symptoms (fever, cough, gastrointestinal symptoms, neurological symptoms, and dysgeusia/anosmia) between vaccinated group and unvaccinated group. Oxygen support, use of steroid, days in hospital, hospital treatment, ICU treatment, death, and poor prognosis were also significantly different.

Conclusion: Compared with the vaccinated group, patients in the unvaccinated group had a more severe clinical manifestations. Vaccines are also protective for infected people.

Keywords: COVID-19; clinical characteristics; epidemiological characteristics; meta-analysis; vaccine.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Cardiovascular Diseases*
  • China
  • Humans
  • Neoplasms*
  • Research Design